Meda receives one-time payment of 45 MEUR

 | Source: Meda AB Meda AB 

Meda receives one-time payment of 45 MEUR

 

Meda has reached an agreement with the Spanish pharma company Almirall
about a respiratory combination project in the Novolizer device that
Meda had certain rights to. The project is in research phase, and
Almirall has purchased Meda's rights for 45 million EUR.

 

 

If questions, please contact: Anders Larnholt, Vice President Corporate
Development & IR ph: +46 709-458 878

Attachments

07222150.pdf
GlobeNewswire